CD34 and acute myeloid leukemia: To determine whether expression of this novel E-selectin ligand is characteristic of primary human AML cells, we repeated these analyses with peripheral blood blasts of two primary human CD34+ AML specimens (AML specimens 1 and 2) and from a CD34-negative AML sample (AML specimen 3) with a high peripheral blood AML blast burden.